top of page
Vincent Miles
Abingworth
Series B
BioTech, Pharmaceuticals
We are Abingworth, a trans-atlantic bio-science investment firm with a deep understanding of both the science and markets we invest in.
$15,000,000
-
$30,000,000
.png){kind=small}
bottom of page
Abingworth
Series B
BioTech, Pharmaceuticals
We are Abingworth, a trans-atlantic bio-science investment firm with a deep understanding of both the science and markets we invest in.
$15,000,000
$30,000,000